Withdrawal of hormone therapy and increased risk of cardiovascular disease

Research output: Contribution to journalArticlepeer-review


Abstract: Many menopause specialists follow the principle of prescribing postmenopausal hormone therapy (HT) for the shortest duration needed, in order to decrease the risk of some related serious adverse effects, such as breast cancer. Based on several large studies, it seems, however, that withdrawal of HT may be associated with immediate, though small increased risk of coronary heart disease and stroke. Cessation of HT correlates with increased risk of fractures as well. This information should be relayed to hormone users while discussing the continuation of HT with their health-care provider, but, since the potential cardiovascular harm is actually very small, it should not deter symptomatic women from using HT when needed.

Original languageEnglish
Pages (from-to)249-251
Number of pages3
Issue number3
StatePublished - 3 May 2016


  • Hormone therapy
  • cardiovascular disease risk


Dive into the research topics of 'Withdrawal of hormone therapy and increased risk of cardiovascular disease'. Together they form a unique fingerprint.

Cite this